[English] 日本語

- PDB-4ay6: Human O-GlcNAc transferase (OGT) in complex with UDP-5SGlcNAc and... -
+
Open data
-
Basic information
Entry | Database: PDB / ID: 4ay6 | ||||||
---|---|---|---|---|---|---|---|
Title | Human O-GlcNAc transferase (OGT) in complex with UDP-5SGlcNAc and substrate peptide | ||||||
![]() |
| ||||||
![]() | TRANSFERASE / GLYCOSYL TRANSFERASE | ||||||
Function / homology | ![]() negative regulation of non-canonical inflammasome complex assembly / protein N-acetylglucosaminyltransferase complex / protein O-acetylglucosaminyltransferase activity / RNA polymerase II C-terminal domain S5 O-GlcNAc transferase activity / RNA polymerase II C-terminal domain S7 O-GlcNAc transferase activity / regulation of insulin receptor signaling pathway / protein O-GlcNAc transferase / positive regulation of transcription from RNA polymerase II promoter by glucose / cardiac septum development / acetylglucosaminyltransferase activity ...negative regulation of non-canonical inflammasome complex assembly / protein N-acetylglucosaminyltransferase complex / protein O-acetylglucosaminyltransferase activity / RNA polymerase II C-terminal domain S5 O-GlcNAc transferase activity / RNA polymerase II C-terminal domain S7 O-GlcNAc transferase activity / regulation of insulin receptor signaling pathway / protein O-GlcNAc transferase / positive regulation of transcription from RNA polymerase II promoter by glucose / cardiac septum development / acetylglucosaminyltransferase activity / regulation of Rac protein signal transduction / regulation of necroptotic process / negative regulation of stem cell population maintenance / positive regulation of cGAS/STING signaling pathway / protein O-linked glycosylation / coronary vasculature development / NSL complex / non-canonical NF-kappaB signal transduction / aorta development / regulation of glycolytic process / RIPK1-mediated regulated necrosis / regulation of gluconeogenesis / regulation of neurotransmitter receptor localization to postsynaptic specialization membrane / protein serine/threonine phosphatase activity / regulation of synapse assembly / mitogen-activated protein kinase p38 binding / Formation of WDR5-containing histone-modifying complexes / Sin3-type complex / positive regulation of stem cell population maintenance / phosphatidylinositol-3,4,5-trisphosphate binding / hemopoiesis / positive regulation of proteolysis / histone acetyltransferase complex / positive regulation of lipid biosynthetic process / heart morphogenesis / mitophagy / negative regulation of proteasomal ubiquitin-dependent protein catabolic process / negative regulation of protein ubiquitination / positive regulation of TORC1 signaling / IRAK2 mediated activation of TAK1 complex / response to nutrient / Alpha-protein kinase 1 signaling pathway / IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation / TICAM1,TRAF6-dependent induction of TAK1 complex / transforming growth factor beta receptor signaling pathway / TRAF6-mediated induction of TAK1 complex within TLR4 complex / protein serine/threonine kinase activator activity / negative regulation of cell migration / JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 / positive regulation of translation / TNFR1-induced NF-kappa-B signaling pathway / cell projection / activated TAK1 mediates p38 MAPK activation / response to insulin / lung development / negative regulation of transforming growth factor beta receptor signaling pathway / circadian regulation of gene expression / mitochondrial membrane / cellular response to glucose stimulus / TAK1-dependent IKK and NF-kappa-B activation / NOD1/2 Signaling Pathway / protein processing / chromatin DNA binding / Regulation of necroptotic cell death / CLEC7A (Dectin-1) signaling / FCERI mediated NF-kB activation / Interleukin-1 signaling / UCH proteinases / chromatin organization / HATs acetylate histones / positive regulation of cold-induced thermogenesis / molecular adaptor activity / in utero embryonic development / positive regulation of MAPK cascade / endosome membrane / Ub-specific processing proteases / apoptotic process / endoplasmic reticulum membrane / regulation of transcription by RNA polymerase II / protein-containing complex binding / positive regulation of DNA-templated transcription / SARS-CoV-2 activates/modulates innate and adaptive immune responses / glutamatergic synapse / negative regulation of transcription by RNA polymerase II / endoplasmic reticulum / signal transduction / positive regulation of transcription by RNA polymerase II / protein-containing complex / nucleoplasm / nucleus / plasma membrane / cytosol / cytoplasm Similarity search - Function | ||||||
Biological species | ![]() | ||||||
Method | ![]() ![]() | ||||||
![]() | Schimpl, M. / Zheng, X. / Blair, D.E. / Schuettelkopf, A.W. / Navratilova, I. / Aristotelous, T. / Ferenbach, A.T. / Macnaughtan, M.A. / Borodkin, V.S. / van Aalten, D.M.F. | ||||||
![]() | ![]() Title: O-Glcnac Transferase Invokes Nucleotide Sugar Pyrophosphate Participation in Catalysis Authors: Schimpl, M. / Zheng, X. / Borodkin, V.S. / Blair, D.E. / Ferenbach, A.T. / Schuettelkopf, A.W. / Navratilova, I. / Aristotelous, T. / Albarbarawi, O. / Robinson, D.A. / Macnaughtan, M.A. / Van Aalten, D.M.F. | ||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 551.8 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | 453.7 KB | Display | ![]() |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Arichive directory | ![]() ![]() | HTTPS FTP |
---|
-Related structure data
-
Links
-
Assembly
Deposited unit | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | ![]()
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Unit cell |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Noncrystallographic symmetry (NCS) | NCS domain:
NCS domain segments:
NCS oper:
|
-
Components
#1: Protein | Mass: 80974.508 Da / Num. of mol.: 4 Fragment: TPR (TRUNCATED) AND CATALYTIC DOMAIN, RESIDUES 197-915 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() #2: Protein/peptide | Mass: 1309.403 Da / Num. of mol.: 4 / Fragment: RESIDUES 389-401 / Source method: obtained synthetically / Source: (synth.) ![]() #3: Chemical | ChemComp-SO4 / #4: Chemical | ChemComp-12V / ( Has protein modification | N | Nonpolymer details | SULFATE ION (SO4): FROM CRYOPROTEC | Sequence details | SYNTHETIC PEPTIDE COVERING RESIDUES 398-401 WITH SER395 REPLACED BY 3-AMINO-ALANINE, DNP ACCORDING ...SYNTHETIC PEPTIDE COVERING RESIDUES 398-401 WITH SER395 REPLACED BY 3-AMINO-ALANINE, DNP ACCORDING TO THE PDB LIGAND DICTIONARY | |
---|
-Experimental details
-Experiment
Experiment | Method: ![]() |
---|
-
Sample preparation
Crystal | Density Matthews: 4.75 Å3/Da / Density % sol: 74.08 % / Description: NONE |
---|---|
Crystal grow | pH: 9.3 / Details: 1.45 M K2HPO4, 10 MM EDTA, 1 % XYLITOL, pH 9.3 |
-Data collection
Diffraction | Mean temperature: 100 K |
---|---|
Diffraction source | Source: ![]() ![]() ![]() |
Detector | Type: ADSC QUANTUM 315 / Detector: CCD / Date: Sep 8, 2011 |
Radiation | Protocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray |
Radiation wavelength | Wavelength: 0.873 Å / Relative weight: 1 |
Reflection | Resolution: 3.3→40 Å / Num. obs: 91074 / % possible obs: 98.2 % / Observed criterion σ(I): 2 / Redundancy: 2.2 % / Rmerge(I) obs: 0.13 / Net I/σ(I): 7.7 |
-
Processing
Software | Name: REFMAC / Version: 5.6.0117 / Classification: refinement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Refinement | Method to determine structure: OTHER Starting model: NONE Resolution: 3.3→40 Å / Cor.coef. Fo:Fc: 0.87 / Cor.coef. Fo:Fc free: 0.822 / SU B: 23.864 / SU ML: 0.383 / Cross valid method: THROUGHOUT / ESU R: 3.781 / ESU R Free: 0.451 / Stereochemistry target values: MAXIMUM LIKELIHOOD Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. RESIDUES 715-718 AND 747-761 ARE DISORDERED
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Solvent computation | Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Displacement parameters | Biso mean: 47.914 Å2
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refinement step | Cycle: LAST / Resolution: 3.3→40 Å
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Refine LS restraints |
|